Acro Biomedical (ACBM) Tax Provisions (2018 - 2019)
Acro Biomedical's quarterly Tax Provisions came in at $9871.0 in Q3 2019, up 163.16% year-on-year from $3751.0 in Q3 2018, and up 155.22% quarter-over-quarter from -$17877.0 in Q2 2019.
Acro Biomedical has reported Tax Provisions for 2 years, with the latest figure at $9871.0 in Q3 2019.
- For the quarter ending Q3 2019, Tax Provisions rose 163.16% year-over-year to $9871.0; the trailing twelve-month figure through Jun 2020 stood at $9871.0 (up 112.46% YoY), and the FY2019 full-year result was -$53130.0, changed N/A from the prior year.
- Tax Provisions for Q3 2019 stood at $9871.0, up from -$17877.0 in the prior quarter.
- The five-year high for Tax Provisions was $59917.0 in Q2 2018, with the low at -$45124.0 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 9,871.00 |
| Jun 30, 2019 | -17,877.00 |
| Mar 31, 2019 | -45,124.00 |
| Dec 31, 2018 | -19,941.00 |
| Sep 30, 2018 | 3,751.00 |
| Jun 30, 2018 | 59,917.00 |
| Mar 31, 2018 | 28,559.00 |